Table 5

The outcomes of haplotype analysis and its potential association with the susceptibility to chronic myeloid leukemia

BlockGeneSNP ID
Haplo-typeFrequency
Unadjusted
Adjusted
SNP1SNP2SNP3OverallCaseControlOmnibus PHaplotype-specific POmnibus PHaplotype-specific P
CSF3 rs25645 rs1042658          
   AC 0.389 0.399 0.380 .15 .58 .55 .28 
   GT 0.338 0.303 0.370  .06*  .64 
   GC 0.273 0.297 0.250  .14  .53 
VEGFA rs699947 rs833061 rs2010963         
  ACG 0.478 0.525 0.433 .04 .01 .30 .12 
  CTC 0.335 0.304 0.364  .09*  .28 
  CTG 0.187 0.171 0.203  .27  .51 
BCL2 rs1801018 rs2279115          
   AC 0.483 0.523 0.447 .12 .04 .16 .09* 
   GA 0.409 0.379 0.436  .12  .06* 
   AA 0.108 0.098 0.117  .43  .74 
FAS rs2234767 rs1800682          
   GT 0.528 0.505 0.551 .39 .22 1.00 .65 
   GC 0.357 0.382 0.334  .18  .70 
   AC 0.114 0.113 0.115  .93  .87 
13 CASP10 rs13010627 rs13006529 rs3834129         
  GTA 0.54 0.518 0.558 .49 .30 .08* .09* 
  GAC 0.386 0.398 0.376  .56  .51 
  AAC 0.074 0.084 0.066  .37  .05* 
BlockGeneSNP ID
Haplo-typeFrequency
Unadjusted
Adjusted
SNP1SNP2SNP3OverallCaseControlOmnibus PHaplotype-specific POmnibus PHaplotype-specific P
CSF3 rs25645 rs1042658          
   AC 0.389 0.399 0.380 .15 .58 .55 .28 
   GT 0.338 0.303 0.370  .06*  .64 
   GC 0.273 0.297 0.250  .14  .53 
VEGFA rs699947 rs833061 rs2010963         
  ACG 0.478 0.525 0.433 .04 .01 .30 .12 
  CTC 0.335 0.304 0.364  .09*  .28 
  CTG 0.187 0.171 0.203  .27  .51 
BCL2 rs1801018 rs2279115          
   AC 0.483 0.523 0.447 .12 .04 .16 .09* 
   GA 0.409 0.379 0.436  .12  .06* 
   AA 0.108 0.098 0.117  .43  .74 
FAS rs2234767 rs1800682          
   GT 0.528 0.505 0.551 .39 .22 1.00 .65 
   GC 0.357 0.382 0.334  .18  .70 
   AC 0.114 0.113 0.115  .93  .87 
13 CASP10 rs13010627 rs13006529 rs3834129         
  GTA 0.54 0.518 0.558 .49 .30 .08* .09* 
  GAC 0.386 0.398 0.376  .56  .51 
  AAC 0.074 0.084 0.066  .37  .05* 
*

P < .1.

P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal